Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
- PMID: 28697108
- PMCID: PMC5529238
- DOI: 10.1097/AOG.0000000000002129
Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery
Abstract
Objective: To compare the costs associated with adjunctive azithromycin compared with standard cefazolin antibiotic prophylaxis alone for unscheduled and scheduled cesarean deliveries.
Methods: A decision analytic model was created to compare cefazolin alone with azithromycin plus cefazolin. Published incidences of surgical site infection after cesarean delivery were used to estimate the baseline incidence of surgical site infection in scheduled and unscheduled cesarean delivery using standard antibiotic prophylaxis. The effectiveness of adjunctive azithromycin prophylaxis was obtained from published randomized controlled trials for unscheduled cesarean deliveries. No randomized study of its use in scheduled procedures has been completed. Cost estimates were obtained from published literature, hospital estimates, and the Healthcare Cost and Utilization Project and considered costs of azithromycin and surgical site infections. A series of sensitivity analyses were conducted by varying parameters in the model based on observed distributions for probabilities and costs. The outcome was cost per cesarean delivery from a health system perspective.
Results: For unscheduled cesarean deliveries, cefazolin prophylaxis alone would cost $695 compared with $335 for adjunctive azithromycin prophylaxis, resulting in a savings of $360 (95% CI $155-451) per cesarean delivery. In scheduled cesarean deliveries, cefazolin prophylaxis alone would cost $254 compared with $111 for adjunctive azithromycin prophylaxis, resulting in a savings of $143 (95% CI 98-157) per cesarean delivery, if proven effective. These findings were robust to a multitude of inputs; as long as adjunctive azithromycin prevented as few as seven additional surgical site infections per 1,000 unscheduled cesarean deliveries and nine additional surgical site infections per 10,000 scheduled cesarean deliveries, adjunctive azithromycin prophylaxis was cost-saving.
Conclusion: Adjunctive azithromycin prophylaxis is a cost-saving strategy in both unscheduled and scheduled cesarean deliveries.
Conflict of interest statement
The authors did not report any potential conflicts of interest.
Each author has indicated that he or she has met the journal’s requirements for authorship.
Figures



Similar articles
-
Adding Azithromycin to Cephalosporin for Cesarean Delivery Infection Prophylaxis: A Cost-Effectiveness Analysis.Obstet Gynecol. 2017 Dec;130(6):1279-1284. doi: 10.1097/AOG.0000000000002333. Obstet Gynecol. 2017. PMID: 29112658
-
Preincision adjunctive prophylaxis for cesarean deliveries a systematic review and meta-analysis.Am J Obstet Gynecol. 2021 Oct;225(4):382.e1-382.e13. doi: 10.1016/j.ajog.2021.04.259. Epub 2021 May 5. Am J Obstet Gynecol. 2021. PMID: 33964219
-
The effectiveness of a cesarean delivery bundle with vaginal preparation, cefazolin, and azithromycin in reducing postoperative infections: A before-and-after study.Int J Gynaecol Obstet. 2025 Jul;170(1):448-455. doi: 10.1002/ijgo.16194. Epub 2025 Feb 1. Int J Gynaecol Obstet. 2025. PMID: 39891485 Free PMC article.
-
A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study.Am J Obstet Gynecol. 2016 Jun;214(6):751.e1-4. doi: 10.1016/j.ajog.2016.02.037. Epub 2016 Feb 18. Am J Obstet Gynecol. 2016. PMID: 26901276
-
Comparing prophylactic use of cefazolin for SSI in cesarean section: a systematic review and meta-analysis.Arch Gynecol Obstet. 2021 Feb;303(2):313-320. doi: 10.1007/s00404-020-05873-z. Epub 2020 Nov 26. Arch Gynecol Obstet. 2021. PMID: 33242142
Cited by
-
Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one-time oral dosing in pregnancy.Clin Transl Sci. 2021 Nov;14(6):2431-2439. doi: 10.1111/cts.13111. Epub 2021 Jul 26. Clin Transl Sci. 2021. PMID: 34310083 Free PMC article.
-
Can the use of azithromycin during labour reduce the incidence of infection among puerperae and newborns? A systematic review and meta-analysis of randomized controlled trials.BMC Pregnancy Childbirth. 2024 Mar 14;24(1):200. doi: 10.1186/s12884-024-06390-6. BMC Pregnancy Childbirth. 2024. PMID: 38486177 Free PMC article.
-
Effect of adjunctive prophylactic macrolides used at the caesarean section on endometritis and surgical site wound infection: A meta-analysis.Int Wound J. 2023 Oct;20(8):3307-3314. doi: 10.1111/iwj.14211. Epub 2023 May 9. Int Wound J. 2023. Retraction in: Int Wound J. 2025 Feb;22(2):e70221. doi: 10.1111/iwj.70221. PMID: 37161646 Free PMC article. Retracted.
-
Azithromycin to Prevent Sepsis or Death in Women Planning a Vaginal Birth.N Engl J Med. 2023 Mar 30;388(13):1161-1170. doi: 10.1056/NEJMoa2212111. Epub 2023 Feb 9. N Engl J Med. 2023. PMID: 36757318 Free PMC article. Clinical Trial.
-
Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial.Lancet Glob Health. 2025 Apr;13(4):e679-e688. doi: 10.1016/S2214-109X(24)00517-5. Lancet Glob Health. 2025. PMID: 40155105 Free PMC article. Clinical Trial.
References
-
- Hamilton BEMJ, Osterman MJK, et al. Births: Final data for 2014. National vital statistics reports. 2015;64(12) - PubMed
-
- Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991–1997. Obstetrics and gynecology. 2003 Feb;101(2):289–96. - PubMed
-
- Weinstein RA, Boyer KM. Antibiotic Prophylaxis for Cesarean Delivery – When Broader Is Better. The New England journal of medicine. 2016 Sep 29;375(13):1284–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical